This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural properties, which make it a valuable intermediate in the synthesis of various biologically active molecules. It is often employed in the development of compounds targeting the central nervous system, particularly in the design of drugs that interact with neurotransmitter systems. Its tetrahydroisoquinoline scaffold is a key feature in the creation of potential therapeutic agents for neurological disorders, such as Parkinson's disease and depression. Additionally, its carboxylic acid group allows for further chemical modifications, enabling the creation of derivatives with enhanced pharmacological properties. Researchers also explore its use in the synthesis of peptidomimetics, which mimic the structure and function of peptides, offering potential applications in drug discovery and development.